Form 4 for INBX Inhibrx Biosciences, Inc.
Accepted 2024-06-07 00:00:00 ET · period of report 2024-06-05 · accession 0002007919-24-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-06-07 | 2024-06-05 | INBX | Kayyem Jon Faiz | Dir | P - Purchase | $17.32 | +57.5K | 1.14M | +5% | +$997.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-05 | P | A | 8,265 | $17.89 | 1,150,410 | I By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | — | — | (F2) The shares were purchased in multiple transactions at prices ranging from $17.81 to $18.10, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 2 | Common | Common Stock | 2024-06-05 | P | A | 49,284 | $17.23 | 1,142,145 | I By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | — | — | (F1) The shares were purchased in multiple transactions at prices ranging from $16.81 to $17.805, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |